Actavis Fentanyl Patch Recall

Tweet

Actavis Recalls All Fentanyl Transdermal System C II Patches Sold in the United States

Free Fentanyl Patch Case Evaluation: If you or a loved one has suffered from a Fentanyl patch overdose, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.

What’s the problem?

The latest Fentanyl patch recall is an expansion of the initial recall of 14 lots of Fentanyl transdermal patches announced on February 17, 2008, which was due to the identification of a possible fold-over defect present in the product. According to Actavis Inc., the new recall is being used as a precautionary measure to assure that all patches are safe from defects.

PriCara®, announced that one lot of 50 microgram/hour (mcg/hr) DURAGESIC® (fentanyl transdermal system) CII patches sold by PriCara in the United States and one lot of 50 mcg/hr fentanyl patches sold by Sandoz Inc. were being recalled. The recall is being conducted in coordination with the U.S. Food & Drug Administration (FDA).

ALZA Corporation of Mountain View, CA, an affiliate of PriCara, manufactured the patches being recalled. DURAGESIC 50 mcg/hr (fentanyl transdermal system) patches and Sandoz Inc. 50 mcg/hr fentanyl transdermal system patches being recalled may have a cut along one side of the drug reservoir.

Do I have a Fentanyl Patch Lawsuit?

The Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Fentanyl patch lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.